GSA Capital Partners’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Buy |
121,364
+90,586
| +294% | +$351K | 0.03% | 960 |
|
|
2025
Q1 | $154K | Sell |
30,778
-52,179
| -63% | -$261K | 0.01% | 1454 |
|
|
2024
Q4 | $598K | Sell |
82,957
-256,638
| -76% | -$1.85M | 0.04% | 755 |
|
|
2024
Q3 | $2.09M | Sell |
339,595
-148,530
| -30% | -$912K | 0.16% | 114 |
|
|
2024
Q2 | $3.25M | Buy |
488,125
+436,972
| +854% | +$2.91M | 0.23% | 30 |
|
|
2024
Q1 | $521K | Sell |
51,153
-158,309
| -76% | -$1.61M | 0.04% | 856 |
|
|
2023
Q4 | $2.36M | Sell |
209,462
-236,406
| -53% | -$2.66M | 0.2% | 77 |
|
|
2023
Q3 | $1.16M | Buy |
445,868
+269,676
| +153% | +$701K | 0.1% | 325 |
|
|
2023
Q2 | $622K | Sell |
176,192
-239,662
| -58% | -$846K | 0.06% | 602 |
|
|
2023
Q1 | $1.76M | Buy |
415,854
+374,233
| +899% | +$1.58M | 0.17% | 104 |
|
|
2022
Q4 | $685K | Sell |
41,621
-1,000
| -2% | -$16.5K | 0.09% | 413 |
|
|
2022
Q3 | $544K | Sell |
42,621
-70,296
| -62% | -$897K | 0.07% | 510 |
|
|
2022
Q2 | $1.32M | Buy |
112,917
+83,434
| +283% | +$976K | 0.2% | 60 |
|
|
2022
Q1 | $180K | Sell |
29,483
-19,514
| -40% | -$119K | 0.02% | 1198 |
|
|
2021
Q4 | $449K | Buy |
+48,997
| New | +$449K | 0.06% | 664 |
|
|
2021
Q1 | – | Sell |
-42,925
| Closed | -$484K | – | 1072 |
|
|
2020
Q4 | $484K | Buy |
+42,925
| New | +$484K | 0.08% | 441 |
|
|
2017
Q2 | – | Sell |
-309
| Closed | -$75K | – | 1646 |
|
|
2017
Q1 | $75K | Buy |
309
+195
| +171% | +$47.3K | ﹤0.01% | 1682 |
|
|
2016
Q4 | $111K | Buy |
114
+18
| +19% | +$17.5K | 0.01% | 1671 |
|
|
2016
Q3 | $83K | Buy |
+96
| New | +$83K | ﹤0.01% | 1711 |
|